The upshot of this new study: Â _possible_ improvements in immunotherapy for pancreatic cancer.
Pancreatic cancer is one of the most lethal cancers, with the survival period after diagnosis being only four to six months. The main reason for the poor prognosis is that chemotherapy, which has had some success in extending lives for patients with other cancers, doesn’t seem to slow down pancreatic cancer.
Embedded Link
Figuring out why drugs don’t work on pancreatic cancer
A mix of cancerous and normal cells alters interactions with the immune system.
Google+: Reshared 1 times
Google+: View post on Google+
0 Comments.